Eli Lilly and Company's latest 10-K report for the year ended December 31, 2024, reveals significant financial growth. The company reported a revenue of $45,042.7 million, marking a 32% increase from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results